Thursday, January 21st, 2021

Emerging Infectious Diseases

FDA pledges continued monitoring of UK SARS-CoV-2 mutation

As a new, more infectious strain of SARS-CoV-2 spreads further from the United Kingdom and across the United States, the U.S. Food and Drug Administration (FDA) is advising that its impact on molecular tests will likely be low, with three approved tests currently affected. The variant, known as... Read More »